GENZ Insider Trading Activity and SEC Form 4 Filings
GENZ insider trading summary
No open-market insider purchases or sales of Genzyme Corp (GENZ) have been reported on SEC Form 4 in the past 12 months.
Latest GENZ insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 8, 2011 | GC Merger Corp. | 10% Owner | Buy | $0 (4,435,393 @ $0.00) |
| Apr 8, 2011 | Sanofi-Aventis | 10% Owner | Buy | $1.24B (16,245,894 @ $76.33) |
| Apr 8, 2011 | GC Merger Corp. | 10% Owner | Buy | $1.24B (16,245,894 @ $76.33) |
| Apr 8, 2011 | Sanofi-Aventis | 10% Owner | Buy | $0 (4,435,393 @ $0.00) |
| Apr 7, 2011 | Sanofi-Aventis | 10% Owner | Buy | $0 (44,891,208 @ $0.00) |
| Apr 7, 2011 | GC Merger Corp. | 10% Owner | Buy | $0 (44,891,208 @ $0.00) |
| Apr 6, 2011 | Sanofi-Aventis | 10% Owner | Buy | $0 (3,947,680 @ $0.00) |
| Apr 6, 2011 | GC Merger Corp. | 10% Owner | Buy | $0 (3,947,680 @ $0.00) |
| Aug 31, 2010 | Jason Amello | Corp Contrllr,ChiefAccntOfficr | Sell | $467K (6,640 @ $70.30) |
| Jul 23, 2010 | Sandford D Smith | Exe VP,President Int'l Group | Sell | $1.3M (20,741 @ $63.75) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.